PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds

Breast cancer is the most commonly diagnosed cancer in women. The high incidence of breast cancer, which is continuing to rise, makes treatment a significant challenge. The PI3K–AKT pathway and its downstream targets influence various cellular processes. In recent years, mounting evidence has shown...

Full description

Bibliographic Details

Published in:	Biomolecules
Main Authors:	Yeqin Yuan, Huizhi Long, Ziwei Zhou, Yuting Fu, Binyuan Jiang
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Subjects:	PI3K–AKT pathway breast cancer natural products clinical trial drugs
Online Access:	https://www.mdpi.com/2218-273X/13/1/93